UBE Corporation (UBEOF) Fair Value & Analysis
Basic Materials · US · Market cap $1.5B
Fair value as of: Jul 21, 2026
From 10 valuation models · updated 20 days ago
Below-average quality, screening 43% undervalued on our models.
What matters now
- The price is below even our cautious bear case ($19.55). The market is more pessimistic than our downside scenario.
- Solid quality (48/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range $10.24 – $16.77 · fair‑value band $19.55 – $25.86 · the $15.29 price screens below the $21.82 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
UBE Corporation (UBEOF) currently trades at $15.29, while our model-based Fair Value estimate is $21.82, implying the stock looks roughly 42.8% undervalued today. The Quality Score stands at 48/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, UBE Corporation generated revenue of $462B at a net margin of 5.2%. Revenue grew 2.4% year over year. It earns a return on equity of 5.6%. Net debt stands at $304B. Fundamentals as of Jul 21, 2026
Our scenario range runs from $19.55 (bear case) to $25.86 (bull case); at $15.29, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 21% below its 52-week high and 7% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at 43%, UBEOF screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 10 models by family
Widest divergence: Economic Profit ($21.82) versus Earnings-Based ($13.62). Highest evidence: Growth-Adj P/E (68).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 47 · Market factors (momentum, volatility) 57
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
UBE Corporation, together with its subsidiaries, engages in the materials and machinery businesses in Japan, Asia, Europe, North America, and internationally. The company operates through Functional Products, High-Performance Urethanes, Pharmaceuticals, Resin and Chemical Products, Machinery, and Others segments.
Full company description
UBE Corporation, together with its subsidiaries, engages in the materials and machinery businesses in Japan, Asia, Europe, North America, and internationally. The company operates through Functional Products, High-Performance Urethanes, Pharmaceuticals, Resin and Chemical Products, Machinery, and Others segments. Its Functional Products segment offers polyimides, separation membranes, ceramics, and separators. The High-Performance Urethanes segment provides urethane resin intermediate, elastomers, and coating products. Its Pharmaceuticals segments engages in the drug discovery and the contract manufacturing and sales of pharmaceutical raw materials and intermediates. The Resin and Chemical Products segment provides composite, nylon polymer, caprolactam, ammonium sulfate, industrial chemicals, and elastomer. Its Machinery segment offers die casting machines, extrusion presses, injection molding machines, ceramics machinery, chemical equipment, crushers, transport machines, dust removers, as well as bridges, steel structures, etc. The Other segment is involved in electricity supply, real estate sales, leasing, and management, etc. The company was formerly known as Ube Industries, Ltd. UBE Corporation was founded in 1897 and is headquartered in Minato, Japan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
UBE Corporation reported revenue of $465B in FY2026 versus $655B in FY2022, a compound −8.2%/yr. Reported net income was $24.0B in FY2026, compounding −0.5%/yr from FY2022.
Watch UBEOF: get an alert when its fair value changes →
Peer Group
Specialty Chemicals · 676 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $489.98 | $222.03 | -55% |
| Nan Ya Plastics Corporation 1303 | 181.50 TWD | 255.83 TWD | +41% |
| Wanhua Chemical Group 600309 | ¥70.04 | ¥68.03 | -3% |
| Novozymes A/S NSISB | kr 428.20 | kr 179.66 | -58% |
| Asian Paints Limited ASIANPAINT | ₹2,689 | ₹668.81 | -75% |
| Solar Industries India Limited SOLARINDS | ₹18,236 | ₹2,793 | -85% |
| Pidilite Industries Limited PIDILITIND | ₹1,560 | ₹351.84 | -77% |
| PT Chandra Asri Pacific Tbk TPIA | 1,805 IDR | 2,888 IDR | +60% |
| Linde India Limited LINDEINDIA | ₹7,115 | ₹757.93 | -89% |
| Berger Paints India Limited BERGEPAINT | ₹493.70 | ₹164.29 | -67% |
Compare UBE Corporation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is UBE Corporation (UBEOF) overvalued or undervalued?
What is the fair value of UBEOF?
What is the quality score of UBEOF?
What is the revenue of UBE Corporation (UBEOF)?
What is the net profit margin of UBEOF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track UBE Corporation and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.